Pharma IQ | 10/22/2010
Public awareness of biobanking is growing and lack of transparency can lead to closure of a biobanking project. David Kaufman, Director of Research and Statistics Genetics and Public Policy Center, John Hopkins University, speaks to Andrea Charles from Pharma IQ, about the growing public interest in biobank research and the concerns and opinions of potential participants. Kaufman also discusses the challenges for biobanking recruitment and retention and future developments...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
GenAI Life Science & Health 2025
September 1 - 3, 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More